BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22308027)

  • 1. Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling.
    Paatero I; Jokilammi A; Heikkinen PT; Iljin K; Kallioniemi OP; Jones FE; Jaakkola PM; Elenius K
    J Biol Chem; 2012 Mar; 287(13):9659-9671. PubMed ID: 22308027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization.
    Liu YV; Hubbi ME; Pan F; McDonald KR; Mansharamani M; Cole RN; Liu JO; Semenza GL
    J Biol Chem; 2007 Dec; 282(51):37064-73. PubMed ID: 17965024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.
    Liu YV; Semenza GL
    Cell Cycle; 2007 Mar; 6(6):656-9. PubMed ID: 17361105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.
    Liu YV; Baek JH; Zhang H; Diez R; Cole RN; Semenza GL
    Mol Cell; 2007 Jan; 25(2):207-17. PubMed ID: 17244529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression.
    Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L
    J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
    Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
    Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland.
    Paatero I; Seagroves TN; Vaparanta K; Han W; Jones FE; Johnson RS; Elenius K
    J Biol Chem; 2014 Aug; 289(32):22459-69. PubMed ID: 24966332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
    Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
    J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermidine/spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha.
    Baek JH; Liu YV; McDonald KR; Wesley JB; Zhang H; Semenza GL
    J Biol Chem; 2007 Nov; 282(46):33358-33366. PubMed ID: 17875644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
    Amir S; Wang R; Simons JW; Mabjeesh NJ
    J Biol Chem; 2009 Apr; 284(17):11142-51. PubMed ID: 19251694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AG490 promotes HIF-1α accumulation by inhibiting its hydroxylation.
    Fernández-Sánchez R; Berzal S; Sánchez-Niño MD; Neria F; Gonçalves S; Calabia O; Tejedor A; Calzada MJ; Caramelo C; Deudero JJ; Ortiz A
    Curr Med Chem; 2012; 19(23):4014-23. PubMed ID: 22709000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase.
    Liu Q; Geng H; Xue C; Beer TM; Qian DZ
    Biochim Biophys Acta; 2015 May; 1853(5):881-91. PubMed ID: 25637186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity.
    Park MH; Bae SS; Choi KY; Min do S
    Exp Mol Med; 2015 Nov; 47(11):e196. PubMed ID: 26611735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line.
    Lee K; Kang JE; Park SK; Jin Y; Chung KS; Kim HM; Lee K; Kang MR; Lee MK; Song KB; Yang EG; Lee JJ; Won M
    Biochem Pharmacol; 2010 Oct; 80(7):982-9. PubMed ID: 20599784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes.
    Lee SH; Che X; Jeong JH; Choi JY; Lee YJ; Lee YH; Bae SC; Lee YM
    J Biol Chem; 2012 Apr; 287(18):14760-71. PubMed ID: 22351759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1α and HIF-2α degradation is differentially regulated in nucleus pulposus cells of the intervertebral disc.
    Fujita N; Chiba K; Shapiro IM; Risbud MV
    J Bone Miner Res; 2012 Feb; 27(2):401-12. PubMed ID: 21987385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production.
    Chua YL; Dufour E; Dassa EP; Rustin P; Jacobs HT; Taylor CT; Hagen T
    J Biol Chem; 2010 Oct; 285(41):31277-84. PubMed ID: 20675386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
    Devine RD; Bicer S; Reiser PJ; Wold LE
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
    Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
    Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.
    Heun Y; Pogoda K; Anton M; Pircher J; Pfeifer A; Woernle M; Ribeiro A; Kameritsch P; Mykhaylyk O; Plank C; Kroetz F; Pohl U; Mannell H
    Mol Ther; 2017 Jul; 25(7):1616-1627. PubMed ID: 28434868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.